Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
This strategic move aims to make Cupid's high-quality products more accessible to consumers nationwide
This transaction is the third acquisition by three different Japanese players in this segment
The pooled prevalence of GERD in the Indian population is 15.6 %
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
DKSH’s Business Unit Consumer Goods further capitalizes on its position to strengthen the consumer health, nutrition, and baby care categories
Subscribe To Our Newsletter & Stay Updated
